Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Hepatic Medicine : Evidence and Research|August 27, 2025
MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular RiskAlaa M Mostafa, Ziyan Pan, Ming-Lung Yu, et al.
Clinical and Experimental Medicine|June 18, 2025
Differential risk factors of fibrosis between lean and obese MAFLDAlaa M Mostafa, Yasser Fouad, Yasmine Gaber, et al.
Hepatology International|May 8, 2024
MAFLD identifies patients with significant hepatic fibrosis better than MASLDZiyan Pan, Said A Al-Busafi, Maheeba Abdulla, et al.
Metabolism: Clinical and Experimental|May 5, 2023
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogrammingJawaher Alharthi, Ziyan Pan, Brian S Gloss, et al.
Hepatobiliary Surgery and Nutrition|August 23, 2024
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impactZiyan Pan, Wai-Kay Seto, Chun-Jen Liu, et al.
Clinical Nutrition ESPEN|May 20, 2026
Health inequity and the risk of MAFLD/MASLDZiyan Pan, Abdulla Al Hassani, Khalid M AlNaamani, et al.
Gastroenterology Report|May 29, 2025
Alternative splicing: hallmark and therapeutic opportunity in metabolic liver diseaseMingqian Jiang, Saleh A Alqahtani, Wai-Kay Seto, et al.
Therapeutic Advances in Endocrinology and Metabolism|May 29, 2024
MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weightZiyan Pan, Maryam Al Khatry, Ming-Lung Yu, et al.
Expert Review of Endocrinology & Metabolism|April 16, 2025
MAFLD vs. MASLD: a year in reviewMingqian Jiang, Amna Subhan Butt, Ian Homer Cua, et al.
Scientific Reports|August 24, 2025
HOMA-IR, an independent predictor of advanced liver fibrosis in metabolic-dysfunction associated fatty liver disease: a cross-sectional study in Egyptian patientsYasser Fouad, Ziyan Pan, Shaymaa Nafady, et al.
Pageof 18